Cathay Pacific General Manager Cargo Commercial Nelson Chin said: “This collaborative approach with the pharmaceutical industry undoubtedly boosts Hong Kong’s reputation as a world-class hub for the handling of these high-value and time-sensitive products.
“As Hong Kong’s home airline, Cathay Pacific is working closely with Airport Authority Hong Kong to develop a pharma ‘corridor’ to connect airport members of Phama.Aero and provide customers with a superior service.”
Pharmaceutical shipments travelling the corridor will be handled in strict compliance with the IATA’s CEIV Pharma standard. Shippers will be assured of seamless airport-to-airport (A2A) temperature-controlled handling, assuring the integrity of the shipments.
Nathan De Valck, Chairman of Pharma.Aero added: “We are excited about Cathay Pacific joining our collaboration group as a full member. Their active involvement in the pilot of the pharma corridor project is a clear added value. In collaboration with Pharma.Aero and our pharma shipper members, key performance indicators of the pharma corridor will be clearly defined, targeting to set A2A pharma handling standards.”